STAMFORD, CT—July 24, 2012—ArisGlobal, a leading provider of solutions to the life science industry, today announced that its customers were fully compliant with the XEVMPD mandate by the July 02, 2012 deadline. ArisGlobal is proud to announce that we have reached a major milestone and that our solutions have helped to file over 10,000 product submissions to the EMA using the electronic gateway solution.
ArisGlobal’s customers, including several from the global top 25 pharmaceutical and life science organizations list, submitted their data leveraging the comprehensive XEVMPD-compliant solutions to meet the required deadline. RegisterTM, agXchange RSMTM and data entry and consulting services are being used together as well as independently to meet these regulatory needs.
“We applaud our customers who have achieved this major milestone. We take pride in the fact that we have been their partner of choice in this important endeavor” said Deepak Abbhi, President and CEO of ArisGlobal. “As a team, we have built significant momentum in this domain and believe that our proven Total Regulatory solution suite will be a timely addition to all the life sciences companies that are already gearing up for the next big regulatory change – ISO IDMP.”
Register 5.3, the comprehensive, XEVMPD-compliant, regulatory information tracking and management system, and agXchange RSM 5.4, the regulatory submissions application, are available for immediate deployment. These products are offered in licensed, on-premise mode or are hosted on agOnDemand™, ArisGlobal's comprehensive Software-as-a-Service (SaaS) delivery platform.
ArisGlobal (www.arisglobal.com) is a leading provider of integrated software solutions for pharmacovigilance and safety, regulatory affairs, clinical research and medical information. Hundreds of life science companies rely on ArisGlobal’s advanced solutions for maintaining regulatory compliance, workflow automation, improving operational efficiency and easily sharing information around the globe.